EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05

Related Keywords

Hoofddorp ,Noord Holland ,Netherlands ,Switzerland ,Frankfurt ,Brandenburg ,Germany ,Swiss ,Matthias Greiffenbergerand Felix Haugg ,Vincenzo Moccia ,Giovanna Puppodellagherardesca ,Research Update ,Group News Service ,Eqs Group ,Swiss Exchange ,Igea Pharma ,Joint Venture ,Unofficial Market ,Adhoc ,Igea ,Dharma ,Ublishes ,Nitial ,Equity ,Research ,Report ,Ith ,Recommendation ,Price ,Target ,